{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Impactful Breakthroughs","title":"Becky Weber - EVP of Sales, Lunit","html":"","width":"100%","height":180,"duration":1603,"description":"What happens when a career built on the cutting edge of health technology suddenly extends to become deeply personal? On this episode of Impactful Breakthroughs, Zach Gobst is joined by longtime friend Becky Weber, the EVP of Sales at Lunit Cancer Screening. Lunit, formerly Volpara Health, provides AI-powered software for breast cancer screening and early detection, supporting over one million screenings annually.\n\nWith 20 years working at the intersection of health and technology, Becky walks through her journey from shadowing surgeries as a teenager, to helping build HealthKit at Apple, to ultimately joining the team at Lunit following her own breast cancer diagnosis. You’ll hear her share why mission alignment has proven to be the secret in Lunit’s successful merger with Volpara, what she believes it’ll take to navigate regulatory hurdles safely in the AI era, and how her perspective on life and career has completely pivoted. \n\nEqual parts personal story and industry insight, this conversation serves as a reminder that the most powerful driver in health technology is the reason behind it.\n\nTimestamps\n\n00:00 Episode Start\n01:35 Becky's journey in health tech\n04:05 A breast cancer diagnosis which changed it all\n08:45 Following your passions\n12:09 Prioritizing team impact over personal politics\n13:45 Why startups beat big companies for the puzzle-solvers\n14:45 Lunit's two-sided platform and the AI difference\n17:10 The interval cancer study proving their work\n20:25 Hiring for personal connection to the mission\n22:10 Mentors who made a difference\n22:50 The convergence of research, product, and diagnosis\n25:00 AI, regulation, and the rocket ship problem\n\nKey Takeaways\nPersonal connection drives performance. Just like in her own story, Becky has found that the candidates with personal ties to breast cancer consistently outperform those who don’t.\nData is already changing what's possible. Lunit's AI would have reduced confirmed interval cancers by a third in a study...","thumbnail_url":"https://img.transistorcdn.com/uUl5NjCb9mY4i46LGv4GWJrr5WVj3WxuYTgjBphYmcc/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85MDM0/ZDk5OWI2YTcwYWRh/NTM0NzIyODViMjU4/ODlmZS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}